ALCO

Alico is no longer the company its income statement describes. The FY2025 headline — a $147M net loss, -436% gross margin, -463% operating margin, -143% ROE — is dominated by a non-cash impairment: depreciation/depletion/amortization exploded to $177M (up 1,077%) as management wrote down the Alico Citrus division under the January 2025 'Strategic Transformation.' The MD&A confirms citrus operations 'substantially wound down' after the April 2025 harvest, the Tropicana contract was terminated by June 2025, and citrus still supplied 93.8% of FY2025 revenue. So the reported revenue base ($44.1M, -5.5%) is evaporating by design — the operating business you can measure is disappearing, and what remains (land management, mining royalties, grazing/hunting leases) was only 6.2% of revenue.

What keeps this out of 'sell/avoid' is the balance sheet and cash generation, which are genuinely healthy despite the loss. Operating cash flow was positive $20.1M (up 166%), cash ballooned to $38.1M (up 1,110%), current assets of $54.9M cover current liabilities of $5.74M nearly 10x, and leverage is modest at 0.91x liabilities/equity with long-term debt of $82.8M. The September 2025 Eighth Amendment refinanced Prudential debt into a MetLife term loan maturing 2034 and reset the LTV covenant to <50% — the company is not under near-term financial stress. Equity of $103M against 7.66M shares is ~$13.45 book value per share, yet the stock trades at $41.80, roughly 3.1x book and a nonsensical 7.3x sales on shrinking revenue.